Dow Down 0.22% Nasdaq Up 0.14%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
30.14 Up 0.03(0.10%) Aug 22, 4:00PM EDT
Prev Close:30.11
Open:30.09
Bid:29.00 x 200
Ask:34.20 x 100
1y Target Est:66.10
Beta:0.46
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:29.53 - 30.34
52wk Range:26.25 - 101.00
Volume:479,012
Avg Vol (3m):1,036,970
Market Cap:890.55M
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEGR

Comparison

Symbol% ChgMkt Cap
AEGRUp 0.10%890.55M
AZNDown 0.19%92.26B
MRKUp 0.54%170.68B
PFEUp 0.35%183.38B

Key Statistics

Forward P/E (1 yr):14.49
P/S (ttm):8.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.86
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback